Theradigm, Inc., a portfolio company of Toucan Capital Fund II, is developing cell-based therapies for treatment of the central nervous system (CNS) disorders. Two different types of cells (1) neural stem cells and (2) bone marrow stromal cells may be applied alone or in combination to constitute unique therapies. Theradigm has a substantial intellectual property base covering use of these cells in CNS applications.
Theradigm, Inc. is an equal opportunity employer. Theradigm, Inc. is committed to equal employment opportunities in all employment practices and decisions including: recruitment, hiring, promotion, training, compensation, and disciplinary action with regard to the terms and conditions of employment. Theradigm, Inc. does not discriminate on the basis of race, religion, national origin, color, age, sex, disability, veteran status, sexual orientation, genetic information, or any other legally protected characteristic. Employees are our most valuable resource. We are committed to fostering an environment where recognition, innovation, communication, and an entrepreneurial spirit are encouraged and rewarded. We attract and retain qualified candidates by providing competitive cash compensation and benefits package. It is Theradigm's policy to provide employees with significant opportunities to develop professionally by providing them with tuition reimbursement and the opportunity to attend professional conferences.
Human Resources
1448 S. Rolling Road
Baltimore, MD 21227
hr@cognatetherapeutics.com
Smita Savant-Bhonsale
Vice President and General Manager ssavant@theradigm.com
Amanda Hendricks Human Resources
ahendricks@theradigm.com
Location
Theradigm, Inc. -East
1448 S. Rolling Road
Baltimore, MD 21227
(410) 455-5697 - Phone
(410) 455-5551 – Fax
